Study tiny gene signals to calm inflammation with aging
This trial studies tiny gene-like signals (microRNAs) to understand and reduce long-term inflammation as people get older. It may help researchers learn how aging affects inflammation and could guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re in the age range of 18–35 or 65 and older
- Your body mass index (BMI) is under 30
- You can understand and sign informed consent
- If you’re 65+: you’re not very frail (Frailty score under 3) and you’re able to do simple thinking/memory tasks (Mini-Cog score above 3)
- You live independently and can move around (ambulatory)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aging affects inflammation in the body. It aims to understand why older people have more inflammation, which may lead to age-related diseases. Participating may help researchers develop new ways to reduce inflammation and slow down aging.
This study tests whether an apple extract supplement can reduce inflammation linked to aging. You will take the supplement or a placebo for 24 weeks and provide samples at home.
This study tests whether taking omega-3 fatty acids (a type of healthy fat) can reduce inflammation and improve immune function in older adults with blood vessel disease. It aims to see if omega-3s can slow down aging-related changes in the body.
This study looks at how physical activity affects oxidative stress and inflammation in older adults. If you join, your routine blood test will be used to measure these markers, helping researchers understand how aging relates to these processes.
This study tests whether a specific type of strength training reduces inflammation in the body for adults aged 60–75. Researchers will measure how your body responds to this training over time.
This study looks at how the immune system ages in people over 60 with inflammatory bowel disease (IBD) and how well newer treatments work for them. It aims to find out if immune aging affects treatment success.
Hear when a new Chronic Inflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.